|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Perhaps you could begin by giving a brief overview of the company?
BlisTech Corporation, a division of Berwind Pharmaceutical Services Inc, provides clinical trial packaging solutions that meet the increasingly demanding requirements of pharmaceutical and biotechnology companies for shorter lead times, zero-tolerance accuracy, patient compliance and child safety. With global headquarters located in Fairfield, New Jersey, BlisTech has additional facilities in the UK and Singapore.
Drawing from your experiences, how would you compare clinical trials packaging requirements in Europe with the US?
In our experience, a greater percentage of European oral dosage form clinical trial supplies are packaged in blister packages than here in the States. Clinical trial blister packages, film/foil blisters sealed within paperboard cardstock, offer benefits that bottles don't. For example, blister packaging is more portable than bottles. Higher patient compliance has been noted using blisters over bottles. Multiple oral drug regimen dosing for clinical trials is best accomplished by incorporating the different drug products onto a blister card coupled with clear, concise graphics. Site personnel find performing end-study reconciliation easier and less time-consuming using blister cards.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EMBALLAGE 2008. World Packaging Exhibition
16-21 November 2008, Paris-Nord Villepinte - France
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
